Europe's new champion in the skilled trades is emerging: Builtech Group becomes part of Dutch VDK Groep
27.11.2025 15:00:00 CET | Business Wire | Press Release
The European skilled trades market is being reshaped: Berlin-based Builtech Group, one of the leading service providers in technical building equipment (TBE), is becoming part of the Dutch VDK Groep, headquartered in Zwolle. The transaction remains subject, inter alia, to clearance by the European Commission. This creates a pan-European provider of building technology services. The new group of companies generates about €2 billion in revenue and employs more than 7,000 people in over 150 businesses across six countries, making it a key enabler in the European infrastructure and building sector.
The decarbonization and digitization of buildings and infrastructure systems are among Europe's largest transformation projects and open up considerable potential for specialized implementation partners. At the same time, the skilled trades are facing profound structural challenges. On the business side, digitization, skills shortages, and increasing sustainability requirements are among the key challenges. In addition, succession issues are becoming more acute for businesses, especially in Germany: Over the next few years, almost 70,000 skilled trades businesses will be facing a handover. The ability to build new skills, work in networks and collaborate more closely across the industry is therefore becoming increasingly important.
This is precisely where the merger of Builtech and VDK comes in. Both companies share the goal of making the skilled trades in Europe more digital, modern, and future-proof – while preserving established local structures and brands. The merger creates a European network that combines traditional expertise with new technological strength. As a pan-European specialist for technical building equipment, the new group of companies will therefore play a significant role in the digital transformation of the skilled trades, the implementation of the energy and heating transition, and the modernization of technical infrastructure in Europe.
The Builtech Group has already established itself as a reliable succession partner in the skilled trades sector in Germany, Austria, Switzerland, and Sweden through successful acquisitions. Its affiliation with the VDK Groep now opens up additional scaling and growth prospects. With its strong employer brand, its own academy, and a powerful innovation department, the group is ideally positioned to reach the next stage of growth and successfully integrate further businesses.
"Our mission is to strengthen the skilled trades in Europe – economically, in terms of people, and technologically. We have laid a strong foundation for this over the past few years. ‘Next level skilled trades’ is what drives us every day. With the VDK Groep, we have the ideal partner at our side to drive this development even faster in our core markets of Germany, Austria, Switzerland, and the Nordics, while giving businesses a secure future. The two groups complement each other perfectly in every respect", says Maurice Frhr. von Dalwigk, CEO of Builtech Group.
The VDK Group, which currently comprises over 100 companies in the Netherlands, Belgium, and Germany, is expanding its presence in Central and Northern Europe with this acquisition. The Dutch company focuses on organic growth and targeted acquisitions – always with the aim of preserving the established identity of the companies and strengthening them in the long term. Together with the Builtech Group, this creates an alliance that combines the best of both worlds: strong local brands, regional responsibility and the pan-European strength to implement large-scale programs and complex TBE projects across the board.
Frans van der Kolk, CEO and founder of VDK Groep, says: “This acquisition is a milestone in the development of VDK Group. Our VDK model – entrepreneurship in strong local companies, supported by a professional central organization – not only works in the Netherlands, but also proves to be highly applicable in other European countries. Adding Builtech Group, we are now not only the market leader in the Netherlands, but also a top three player in Germany. Our core values are the foundation for this: entrepreneurship, sustainable continuity in business operations, and job satisfaction. I therefore look forward to welcoming our new German colleagues to our family of VDK companies."
Investor AUCTUS Capital Partners also views the transaction positively: “Builtech has developed into a European growth driver at remarkable speed. The sale to VDK Groep creates the ideal structure for further expanding the model – with strong regional roots and secure succession for a large number of medium-sized companies”, says Dr. Daniel Meuthen, Partner at AUCTUS Capital Partners.
About Builtech
Builtech is a dynamically growing group of currently 51 leading companies and more than 2,000 employees in German-speaking countries (DACH) and Sweden. As an integrated 360° provider in the field of technical building equipment (TBE), Builtech is playing a key role in shaping the transformation of the building sector. The group brings together companies with strong regional roots under one roof, enabling significant synergy effects and knowledge transfer. Builtech ensures suitable succession, thus securing the future and further development of local companies while preserving their individual character. The group offers comprehensive solutions in the areas of electrical & building automation, plumbing & heating, air conditioning & ventilation, and technical building envelopes. Builtech's mission is to bring skilled trade into the future and the future into skilled trade. Further information is available at: www.builtech.de
About VDK Groep
VDK Groep, founded in 2013 by CEO Frans van der Kolk, is a Dutch integrated installation and service organization. The company provides multidisciplinary solutions in the fields of electrical engineering, climate control, infrastructure technology, security technology, and Building Intelligence & IT. With more than 5,000 professionals, VDK realizes and maintains complex installations for sectors such as education, healthcare, retail, housing, and government. VDK Groep consists of 107 entities in the Netherlands, Germany, and Belgium. The local companies are supported from regional offices in Zwolle, The Hague, and Eindhoven, with the national team based in Zwolle. The company is steadily expanding its presence in the Netherlands and Germany, with a clear long-term focus on the whole of Europe. VDK is a financially healthy Dutch company with a solid foundation and an ambitious buy-and-build strategy within the European installation sector. In 2024, the group achieved more than €1 billion revenue. Thanks to its scale, innovative strength, and broad expertise, VDK Groep is a reliable partner for innovative, sustainable, and future-oriented installation technology. Further information is available at: https://vdkgroep.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20251127925831/en/
Contacts
Addick Addicks, presse@builtech.de, - addicks@builtech.de +49 170 65 41 348
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom